Showing 1–16 of 114 resultsSorted by popularity
Testosterone Cypionate is a long-acting injectable androgen with a cyclopentylpropionate ester that provides gradual systemic release and steady androgen receptor binding. It drives myofibrillar protein transcription and nitrogen retention with stable pharmacokinetics.
Trenbolone Enanthate is a long-acting 19-nor injectable androgen with a trienic bond structure for extreme androgen receptor affinity and zero aromatization potential. The enanthate ester provides extended steady-state anabolic signaling for lean mass research.
Sildenafil (Viagra) is a potent PDE5 inhibitor that prevents cGMP degradation in vascular smooth muscle, promoting sustained vasodilation and blood flow. Its 3-5 hour half-life provides a reliable research window for erectile function and pulmonary hypertension studies.
Clenbuterol is a long-acting Beta-2 adrenergic agonist with a 36-39 hour half-life that activates cAMP/PKA signaling to upregulate hormone-sensitive lipase. A potent research tool for investigating targeted lipolysis, thermogenesis, and metabolic rate enhancement.
Anavar (Oxandrolone) is a mild C17-alpha-alkylated DHT derivative with a 9-10 hour half-life that promotes lean tissue preservation through androgen receptor activation and glucocorticoid receptor inhibition. Distinguished by minimal aromatization and low hepatotoxicity.
Testosterone Enanthate is a long-acting injectable androgen with a 10.5-day half-life that provides sustained androgen receptor activation through gradual heptanoate ester cleavage. A basic compound for investigating androgenic signaling and muscle protein synthesis.
Proviron (Mesterolone) is a 1-methyl DHT derivative with exceptionally high affinity for SHBG, effectively displacing endogenous testosterone to increase free androgen concentrations. It provides oral androgen receptor activation without significant hepatic strain from C17-alkylation.
Trenbolone Acetate is a potent short-acting 19-nor injectable androgen featuring a trienic bond structure that precludes aromatization while enhancing receptor affinity. Its 48-hour half-life and glucocorticoid receptor inhibition drive exceptional nitrogen retention and lean tissue accretion.
Dianabol (Methandienone) is a potent C17-alpha-alkylated testosterone derivative with a delta-1 double bond that enhances anabolic signaling and nitrogen retention. A fundamental oral androgen for studying accelerated protein synthesis and rapid muscle hypertrophy.
Anastrozole (Arimidex) is a benzyltriazole-derived Type II non-steroidal aromatase inhibitor that competitively binds the heme group of CYP19A1, blocking androgen-to-estrogen conversion. A reversible, high-fidelity tool for precise estrogen modulation research.
Clomiphene Citrate (Clomid) is a triarylethylene SERM that competitively blocks hypothalamic estrogen receptors, lifting negative feedback inhibition to stimulate endogenous LH and FSH secretion. A pillar compound for HPTA restoration and fertility research.
Sustanon 250 is a multi-ester testosterone blend (Propionate, Phenylpropionate, Isocaproate, Decanoate) engineered for a bimodal pharmacokinetic profile with a 15-18 day terminal half-life. It provides both immediate receptor saturation and prolonged steady-state androgen levels.
NAD+ (Nicotinamide Adenine Dinucleotide) is the essential cellular coenzyme that serves as a rate-limiting substrate for sirtuin activation, PARP-mediated DNA repair, and mitochondrial ATP synthesis via the electron transport chain. A core molecule for anti-aging and cellular energy research.
NPP (Nandrolone Phenylpropionate) is a fast-acting 19-nortestosterone derivative with a 2.5-4.5 day half-life that enhances collagen synthesis and mineral content in bone and synovial tissues. It provides rapid steady-state concentration compared to the longer-acting Decanoate variant.
Tamoxifen (Nolvadex) is a selective estrogen receptor modulator that acts as a competitive antagonist in breast tissue and at the hypothalamus, triggering LH and FSH release. With a 5-7 day half-life, it is a fundamental tool for estrogen blockade and HPTA restoration research.
TrenMix-200 is a triple-ester Trenbolone blend (Acetate, Enanthate, Hexahydrobenzylcarbonate) at 200mg/ml, providing staggered release kinetics for sustained 19-nor androgenic signaling. Its trienic bond structure precludes aromatization while maintaining extreme receptor affinity.
End of content
End of content
No products in the cart.
